Baicalin prevents pulmonary arterial remodeling in vivo via the AKT/ERK/NF-κB signaling pathways
Pulmonary arterial hypertension is a rapidly progressive and often fatal disease. As the pathogenesis of pulmonary arterial hypertension remains unclear, there is currently no good drug for pulmonary arterial hypertension and new therapy is desperately needed. This study investigated the effects and...
Main Authors: | Guosen Yan, Jinxia Wang, Tao Yi, Junfen Cheng, Haixu Guo, Yuan He, Xiaorong Shui, Zeyong Wu, Shian Huang, Wei Lei |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-11-01
|
Series: | Pulmonary Circulation |
Online Access: | https://doi.org/10.1177/2045894019878599 |
Similar Items
-
Baicalin Liposome Alleviates Lipopolysaccharide-Induced Acute Lung Injury in Mice via Inhibiting TLR4/JNK/ERK/NF-κB Pathway
by: Yu Long, et al.
Published: (2020-01-01) -
Quercetin Inhibits Pulmonary Arterial Endothelial Cell Transdifferentiation Possibly by Akt and Erk1/2 Pathways
by: Shian Huang, et al.
Published: (2017-01-01) -
Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway
by: Lu Jiang, et al.
Published: (2019-06-01) -
Anti-Remodeling Effects of Xanthohumol-Fortified Beer in Pulmonary Arterial Hypertension Mediated by ERK and AKT Inhibition
by: Ana Filipa Silva, et al.
Published: (2019-03-01) -
Baicalin Alleviates Lipopolysaccharide-Induced Liver Inflammation in Chicken by Suppressing TLR4-Mediated NF-κB Pathway
by: Ping Cheng, et al.
Published: (2017-08-01)